+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Molecular modeling and mutagenesis of the ligand-binding pocket of the mGlu3 subtype of metabotropic glutamate receptor



Molecular modeling and mutagenesis of the ligand-binding pocket of the mGlu3 subtype of metabotropic glutamate receptor



Journal of Neurochemistry 86(4): 947-957



A homology model of the extracellular domain of the mGlu3 subtype of metabotropic glutamate (mGlu) receptor was generated and tested using site-directed mutagenesis, a radioligand-binding assay using the Group II selective agonist (2S,2'R,3'R)-2-(2',3'-(3H)dicarboxycyclopropyl) glycine ((3H) DCG-IV), and in a fluorescence-based functional assay in live transiently transfected human embryonic kidney cells. Ten of the 12 mGlu3 mutants (R64A, R68A, Y150A, S151A, T174A, D194A, Y222A, R277A, D301A and K389) showed either no binding or a 90% or greater loss of specific (3H)DCG-IV binding. Several analogous mutations in mGlu2 supported the results obtained with mGlu3. These results demonstrate that the binding of (3H)DCG-IV to mGlu3 is exceptionally sensitive to mutagenesis-induced perturbations. In silico docking of DCG-IV into the agonist binding pocket of mGlu3 facilitated the interpretation the mutagenesis results. Tyrosines 150 and 222, and arginine 277 show close contacts with the third carboxylic acid group in DCG-IV, which is not present in glutamate or (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine (L-CCG-I). Mutation of these three amino acids to alanine resulted in a near complete loss of receptor activation by DCG-IV and retention of near wild-type affinity for L-CCG-I. It is proposed that hydrogen bonding between this carboxylate and tyrosines 150 and 222 and arginine 277 provide a partial explanation for the high affinity and Group II selectivity of DCG-IV. These findings define the essential features of the ligand-binding pocket of mGlu3 and, together with other recent studies on mGlu receptors, provide new opportunities for structure-based drug design.

(PDF emailed within 0-6 h: $19.90)

Accession: 011009655

Download citation: RISBibTeXText

PMID: 12887692

DOI: 10.1046/j.1471-4159.2003.01906.x


Related references

A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding. Journal of Psychopharmacology 31(12): 1519-1526, 2017

Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine. Molecular Pharmacology 64(4): 823-832, 2003

The unique ligand-binding pocket for the human prostacyclin receptor. Site-directed mutagenesis and molecular modeling. Journal of Biological Chemistry 278(6): 4250-4257, 2002

Probing the ligand-binding domain of the mGluR4 subtype of metabotropic glutamate receptor. Journal of Biological Chemistry 274(47): 33488-33495, 1999

Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. Journal of Biological Chemistry 273(21): 13089-13096, 1998

Ligand binding to the amino-terminal domain of the mGluR4 subtype of metabotropic glutamate receptor. Journal of Biological Chemistry 274(15): 10008-10013, 1999

Amino acid mutagenesis of the ligand binding site the dimer interface of the metabotropic glutamate receptor 1. Identification of crucial residues for setting the activated state. Journal of Biological Chemistry 278(6): 4314-4321, February 7, 2003

Amino acid mutagenesis of the ligand binding site and the dimer interface of the metabotropic glutamate receptor 1. Identification of crucial residues for setting the activated state. Journal of Biological Chemistry 278(6): 4314-4321, 2002

Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor. Neuropharmacology 47(7): 994-1007, 2004

Molecular similarities in the ligand binding pockets of an odorant receptor and the metabotropic glutamate receptors. Journal of Biological Chemistry 278(43): 42551-9, 2003

Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes. Molecular Pharmacology 71(5): 1369-1380, 2007

Identification of Essential Residues Involved in the Glutamate Binding Pocket of the Group Ii Metabotropic Glutamate Receptor. Molecular Pharmacology 60(5): 944-954, 2001

Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor. Molecular Pharmacology 60(5): 944-954, 2001

Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology. Molecular Pharmacology 83(5): 991-1006, 2013

Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1. Journal of Biological Chemistry 279(34): 35526-35534, 2004